Surgery Partners, Inc.SGRYNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+9.0%
5Y CAGR+11.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+9.0%/yr
vs +9.6%/yr prior
5Y CAGR
+11.4%/yr
Consistent
Acceleration
-0.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$2.54B+7.4%
2024$2.37B+13.0%
2023$2.10B+6.7%
2022$1.96B+13.3%
2021$1.73B+17.1%
2020$1.48B+5.2%
2019$1.41B+3.4%
2018$1.36B+34.3%
2017$1.01B+23.5%
2016$821.20M-